BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8669856)

  • 1. A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.
    Wu MS; Lee WC; Lin JT; Wang HP; Wang TH; Chen CJ
    Anticancer Res; 1995; 15(6B):2739-43. PubMed ID: 8669856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
    Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
    Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of gastric adenocarcinoma using a scoring system: combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin.
    Lin JT; Lee WC; Wu MS; Wang JT; Wang TH; Chen CJ
    J Gastroenterol; 1995 Apr; 30(2):156-61. PubMed ID: 7773344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
    Farinati F; Di Mario F; Plebani M; Cielo R; Fanton MC; Valiante F; Masiero M; De Boni M; Della Libera G; Burlina A
    Ital J Gastroenterol; 1991 May; 23(4):194-6. PubMed ID: 1751813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs.
    Kemppainen H; Räihä I; Sourander L
    Hepatogastroenterology; 1997; 44(16):1143-6. PubMed ID: 9261614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
    Schlemper RJ; van der Werf SD; Biemond I; Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):33-9. PubMed ID: 8900906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical and immunological criteria for evaluation of gastric mucosa in tumor and non-tumor pathology].
    Uspenskiĭ MN; Kalinovskiĭ VP; Tkachenko EI
    Vopr Onkol; 2007; 53(3):304-10. PubMed ID: 18198612
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptic disease and 24-hr patterns of serum gastrin and pepsinogen.
    Mazzetti di Pietralata M; Cugini P; Bersacchi F; Piccinni Leopardi M; Samaritani R; Leonardi C
    Prog Clin Biol Res; 1987; 227A():389-95. PubMed ID: 3601974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
    Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
    J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in prevalence of peptic ulcer and gastric adenocarcinoma at the Policlínico Peruano Japones, Lima, Peru, between the years 1985 and 2002. Analysis of 31,446 patients.
    Ramírez-Ramos A; Watanabe-Yamamoto J; Takano-Morón J; Gilman RH; Recavarren Arce S; Arias-Stella J; Yoshiwara-Wakabayashi E; Rodríguez-Ulloa C; Miyagui-Maeda J; Chinga-Alayo E; Mendoza-Requena D; Leey-Casella J; Rosas-Aguirre A; Velapatiño-Cochachi B; Guerra Valencia D
    Acta Gastroenterol Latinoam; 2006 Sep; 36(3):139-46. PubMed ID: 17407990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.